Delving into the Latest Updates on Mundipharma Pty Ltd. with Synapse

A multi-centre, randomised phase 2 clinical trial of early salvage radiotherapy versus surveillance on the incidence of biochemical recurrence after radical prostatectomy for men with prostate cancer, incorporating clinical and imaging-based risk stratification.

开始日期2023-02-01

申办/合作机构

Mundipharma Pty Ltd.

NCT01961271 / Completed临床4期

Multicentre Study To Evaluate Efficacy And Safety Of Buprenorphine Transdermal Patch (Norspan) In Chronic Non-Malignant Pain Of Moderate To Severe Intensity Due To Osteoarthritis, Rheumatoid Arthritis, Lower Back Pain And Joint / Muscle Pain, When Opioid Is Needed For Analgesia

The purpose of this study is to assess the efficacy of the buprenorphine transdermal patch (Norspan® or Sovenor® transdermal patch) in patients with chronic non-malignant pain of moderate to severe intensity due to osteoarthritis, rheumatoid arthritis, lower back pain and joint/muscle pain, who are not adequately responding to non-opioid painkillers.

开始日期2013-06-01

申办/合作机构

Mundipharma Pte Ltd.

[+3]

ACTRN12609000647235 / Active, not recruiting临床3期

A Multicentre, Randomised, Double-Blind, Parallel Group Comparison Of The Efficacy And Safety Of Transdermal Buprenorphine (Norspan'registered trade mark' Buprenorphine transdermal system [BTDS]) And Placebo In Patients With Diabetic Peripheral Neuropathic Pain.

开始日期2010-03-05

申办/合作机构

Mundipharma Pty Ltd.

100 项与 Mundipharma Pty Ltd. 相关的临床结果

登录后查看更多信息

0 项与 Mundipharma Pty Ltd. 相关的专利（医药）

登录后查看更多信息

100 项与 Mundipharma Pty Ltd. 相关的药物交易

登录后查看更多信息

100 项与 Mundipharma Pty Ltd. 相关的转化医学

登录后查看更多信息

组织架构

使用我们的机构树数据加速您的研究。

登录

或

查看完整样例数据

管线布局

2024年12月22日管线快照

管线布局中药物为当前组织机构及其子机构作为药物机构进行统计，早期临床1期并入临床1期，临床1/2期并入临床2期，临床2/3期并入临床3期

批准上市

3

登录后查看更多信息

当前项目

药物(靶点)	适应症	全球最高研发状态

普拉曲沙 ( DHFR )	外周T细胞淋巴瘤更多	批准上市
他氟前列素 ( PGF2α )	开角型青光眼更多	批准上市
盐酸纳洛酮/盐酸羟考酮 ( Opioid receptors )	重度疼痛更多	批准上市